Bacterial Pneumonia Boosts Cardiac Event Risk – APhA submits compounding comments to FDA.

4Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Bacterial Pneumonia Boosts Cardiac Event Risk – APhA submits compounding comments to FDA. – (866) 348-2889.

Patients hospitalized with acute pneumonia are at increased short-term risk of major adverse cardiovascular events (MACE), but it has been widely unknown which type of pneumonia is associated with a greater risk.

In a new study conducted by investigators from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City, it was discovered that patients diagnosed with bacterial pneumonia had a 60% greater risk of a MACE such as heart attack (MI), stroke, or death than patients who had been diagnosed with viral pneumonia.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.